Natera

Natera

Yahoo Finance • 13 days ago

Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar

Check out the companies making headlines yesterday: AutoZone (NYSE:AZO): Auto parts and accessories retailer AutoZone (NYSE:AZO) rose by 6.1% on Tuesday after the company reported fourth-quarter earnings per share above Wall Street expect... Full story

Yahoo Finance • 22 days ago

This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy?

Stanley Druckenmiller has quite a long and distinguished career as an investor. Much of this has to do with high-risk bets that have paid off enormously, such as when he and his boss, George Soros at Quantum Fund, shorted the U.K. pound fo... Full story

Yahoo Finance • 27 days ago

Jim Cramer Calls Natera (NTRA) “a Promising Story”

Natera, Inc. (NASDAQ:NTRA) is expanding across oncology, women's health and organ transplantation, but Jim Cramer says the stock's valuation has become difficult to justify after a sharp rally. During the September 3 episode of Mad Money,... Full story

Yahoo Finance • last month

Ten healthcare stocks leading in year-over-year CapEx growth

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images With the second-quarter earnings season now largely behind us, investors are turning their attention to how healthca... Full story

Yahoo Finance • last month

Vanguard Growth ETFs Compared: Should You Go for Megacap or Small-Cap Growth Stocks to Finish Out 2026?

Vanguard Morningstar Mega Cap Growth ETF (NYSEMKT:MGK) and Vanguard Morningstar Small-Cap Growth ETF (NYSEMKT:VBK) offer low-cost access to growth-oriented stocks but target opposite ends of the market-capitalization spectrum. Vanguard Mo... Full story

Yahoo Finance • last month

Natera & Angiex Partner to Evaluate AGX101 Response With Signatera

Natera NTRA recently announced a collaboration with Angiex, Inc. to assess treatment response to AGX101, an investigational nuclear-delivered antibody-drug conjugate (ND-ADC), using its Signatera test. The Phase 1 trial is evaluating AGX10... Full story

Yahoo Finance • last month

3 Healthcare Stocks with Promising Prospects

3 Healthcare Stocks with Promising Prospects Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is on... Full story

Yahoo Finance • last month

How Investors May Respond To Natera (NTRA) New MRD Trial Deal And Duquesne Stake Expansion

Natera recently announced a collaboration with Kupando Therapeutics to supply its Latitude tissue-free MRD assay for a Phase 1 immunotherapy trial in multiple skin cancers, expanding the use of its technology in oncology research. At the s... Full story

Yahoo Finance • last month

Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal

Billionaire Stanley Druckenmiller, who runs the Duquesne Family Office hedge fund, has been loading up on healthcare stocks. A year ago, healthcare stocks represented almost 22% of the fund's portfolio. Today, that representation is up to... Full story

Yahoo Finance • last month

Should JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) Be on Your Investing Radar?

The JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) was launched on April 14, 2020, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Blend segment of the US equity market. The fund is sp... Full story

Yahoo Finance • last month

Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.

When you look at Stanley Druckenmiller's latest 13F, the headline names are familiar. He added Amazon and Alphabet again. That fits the narrative most people expect from a billionaire macro investor. What surprised me was that his single b... Full story

Yahoo Finance • last month

3 Large-Cap Stocks Worth Investigating

3 Large-Cap Stocks Worth Investigating Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smal... Full story

Yahoo Finance • last month

Billionaire Druckenmiller makes cancer stock his #1 buy for a reason

The legendary billionaire macro trader, Stanley Druckenmiller, has built his career on a simple habit. When he finds a bet he believes in, he sizes it big and watches it closely. Right now, that bet is a cancer-testing company most people... Full story

Yahoo Finance • 2 months ago

Making Drugs With AI: Biopharma Giants Gear Up For New Arena

The biggest names behind biotech stocks are investing richly in artificial intelligence with the goal of speeding up drug development. Continue Reading... Full story

Yahoo Finance • 2 months ago

Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story?

During his three decades as manager of the hedge fund Duquesne Capital, Stanley Druckenmiller averaged annual returns of around 30%, beating not just the S&P 500 but also many other major hedge funds. Druckenmiller wound down his fund in 2... Full story

Yahoo Finance • 2 months ago

Zacks Investment Ideas feature highlights: NVDA, GOOGL, AMZN, INTC and others

For Immediate Release Chicago, IL – August 18, 2026 – Today, Zacks Investment Ideas feature highlights Intel INTC, CoreWeave CRWV, Nebius NBIS, Snowflake SNOW, Google GOOGL, Meta Platforms META, NVDA NVDA, Cerebras CBRS, Micron MU, ASML H... Full story

Yahoo Finance • 2 months ago

Stanley Druckenmiller builds $120 million bet on major tech stock

Tech investors are back in record territory, but the relentless rally carries an expensive question. The Nasdaq is up 15% in 2026, even as the AI arms race continues to accelerate, according to Reuters. Consensus estimates put combined C... Full story

Yahoo Finance • 2 months ago

Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know

Key Points The transaction involved 731 shares with an estimated value of $195,901 as of the August 3 transaction date. The disposition reduced the executive's total equity holdings by 0.03%. The shares were sold from a direct position, w... Full story

Yahoo Finance • 2 months ago

A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It

Key Points The transactions involved 795 shares sold for an estimated total value of about $216,000. The disposition reduced Michael Burkes Brophy's direct equity holdings by 2%. The activity was non-discretionary, executed to satisfy tax... Full story

Yahoo Finance • 2 months ago

A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know

Key Points The co-founder sold 9,150 shares for a total transaction value of approximately $2.9 million, based on the weighted-average execution price. The disposition reduced the insider's total equity holdings by 3% across direct and in... Full story